Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Context The optimal treatment for men with high-risk localized or locally advanced prostate
cancer (PCa) remains unknown. Objective To perform a systematic review of the existing …

Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …

The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …

Patients with high-risk prostate cancer treated with curative intent are at an increased risk of
biochemical recurrence, metastatic progression and cancer-related death compared with …

Prostate cancer is the most frequent nonskin cancer and second most common cause of
cancer-related deaths in man. Prostate cancer is a clinically heterogeneous disease with …

PURPOSE Radical prostatectomy (RP) alone is often inadequate in curing men with
clinically localized, high-risk prostate cancer (PC). We hypothesized that chemohormonal …

Prostate cancer can progress rapidly after diagnosis, but can also become undetectable
after curative intent radiation or surgery, only to recur years or decades later. This capacity to …

Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Simple Summary Prostate carcinoma (PCa) is the most common tumor in men with an
increasing age-associated risk. Several therapy strategies, one of which is docetaxel (DX) …